Hemostatic gene polymorphisms and the prevalence of thrombohemorrhagic complications in polycythemia vera and essential thrombocythemia.

被引：0
|
作者：
Afshar-Kharghan, V
Lopez, JA
Gray, LA
Padilla, A
Borthakur, G
Roberts, SC
Pruthi, RK
Tefferi, A
机构：
[1] Baylor Coll Med, Thrombosis Res Sect, Houston, TX 77030 USA
[2] Univ Texas, Sch Med, Div Hematol Oncol, Houston, TX USA
[3] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1967
引用
收藏
页码：471A / 471A
页数：1
相关论文
共 50 条
  • [41] Epidemiology of the myeloproliferative disorders polycythemia vera and essential thrombocythemia
    Johansson, P
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (03): : 171 - 173
  • [42] Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice
    Tefferi, Ayalew
    Barbui, Tiziano
    MAYO CLINIC PROCEEDINGS, 2015, 90 (09) : 1283 - 1293
  • [43] Platelet activation and inhibition in polycythemia vera and essential thrombocythemia
    Patrono, Carlo
    Rocca, Bianca
    De Stefano, Valerio
    BLOOD, 2013, 121 (10) : 1701 - 1711
  • [44] Acute coronary disease in essential thrombocythemia and polycythemia vera
    Rossi, C
    Randi, ML
    Zerbinati, P
    Rinaldi, V
    Girolami, A
    JOURNAL OF INTERNAL MEDICINE, 1998, 244 (01) : 49 - 53
  • [45] Part 2: Essential thrombocythemia and polycythemia vera - Preface
    Mammen, EF
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (04): : 305 - 306
  • [46] Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia
    Dingli D.
    Tefferi A.
    Current Hematologic Malignancy Reports, 2006, 1 (2) : 69 - 74
  • [47] Management of symptoms in polycythemia vera and essential thrombocythemia patients
    Radia, Deepti
    Geyer, Holly L.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 340 - 348
  • [48] Is myocardial infarction as frequent in essential thrombocythemia as in polycythemia vera?
    Randi, ML
    Rossi, C
    Zerbinati, P
    Girolami, A
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS182 - PS182
  • [49] Evidence and expertise in the management of polycythemia vera and essential thrombocythemia
    Finazzi, G.
    Barbui, T.
    LEUKEMIA, 2008, 22 (08) : 1494 - 1502
  • [50] Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis
    Silver, Richard T.
    Kiladjian, Jean-Jacques
    Hasselbalch, Hans Carl
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (01) : 49 - 58
12345